雷科防務(002413.SZ):面向航空安全領域推出了鳥情探驅管一體化系統
格隆匯5月10日丨雷科防務(002413.SZ)在投資者互動平台表示,公司面向航空安全領域推出了鳥情探驅管一體化系統,主要完成機場鳥情的探測識別、驅離、管理一體化工作,已順利完成定型試驗,並進入小批量交付階段,已落地北京大興國際機場、成都天府國際機場;C919 國產大型客機是我國大飛機重大專項重點型號之一,公司承接的 C919 某機載雷達天線國產化項目,在材料符合性、供應鏈可控性、發泡工藝一致性等方面均取得了突破性進展,已轉入小批量試生產階段,該突破解決了我國航空事業卡脖子問題,併成功應用到軍、民用多個機型。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.